For a long time, Ukraine has been showing negative dynamics between birth and death rates. The demographic situation in any country is an important indicator. Therefore, the issue of women's health and ability to reproduce is significant and urgent. The purpose of the study was to analyze current data from domestic and foreign literature on provoking factors, etiology and pathogenesis of uterine fibroids, new approaches to treatment and the impact of this pathology on a woman's reproductive potential. Hyperplastic processes of the uterus in women of reproductive age are among the most common gynecological diseases. Uterine leiomyoma is the most common benign proliferative pathology. The presence of uterine leiomyoma leads to disorders of women's reproductive health, is one of the causes of infertility, in addition, significantly affects the quality of life of the patient due to constant pain, excessive uterine bleeding, dysfunction of adjacent organs. Many studies confirm the unfavorable course of pregnancy and the postpartum period in women with fibroids, namely: complicated pregnancy, reproductive losses, birth defects and postpartum complications. Despite the intensive work of scientists, the implementation of a large number of studies, the pathogenesis to this day remains multifaceted and poorly understood. Results and discussion. After analyzing current data from domestic and foreign literature on provoking factors, etiology and pathogenesis of uterine fibroids, the review article presents data on current opportunities, new approaches to treatment and the impact of this pathology on a woman's reproductive potential. For a long time, the pineal gland with the hormone melatonin has not been studied. During the scientific research, the review of the current domestic and foreign literature on the potential inhibitory effect of melatonin on uterine fibroid cells, and the direct and indirect effect on fertility was reviewed and analyzed. As a result of analysis of experimental and clinical data presented in the literature, it can be argued that melatonin has the ability not only to regulate biological rhythms, but also that it is promising to study metabolic and immunomodulatory effects, as well as antitumor effects, which gives us a chance to reduce surgery of this group of patients. Conclusion. The information presented in the review suggests that melatonin has the potential as a therapeutic agent for clinical trials against uterine leiomyoma in women of reproductive age. Therefore, there is a need to study deeply the etiopathogenesis of uterine leiomyoma and in particular the effect of melatonin on growth, reduction of surgical interventions, the impact on the pre- and postoperative period, and to determine melatonin as a therapeutic drug

Keywords: reproductive health, uterine leiomyoma, melatonin, hysterectomy, estrogen, myometrium, progesterone

Full text: PDF (Ukr) 306K

1. Semeniak AV, Yuz'ko OM, Nitsovych IR. Leiomioma matky ta vahitnist' [Uterine leiomyoma and pregnancy]. Neonatolohiia, khirurhiia ta perynatal'na medytsyna. 2018;2(28):93-8. [Ukrainian]
2. Patapov VO, Shpon'ka IS, Medvediev MV, Bondarieva VO, Honcharova-Bilets'ka HS. Suchasni pryntsypy diahnostyky ta orhanozberihaiuchoho likuvannia leiomiomy matky (navchal'nyi posibnyk dlia studentiv likariv-interniv zahal'noho profiliu, akusher-hinekolohiv ta patalohoanatomam) [Modern principles of diagnosis and organ-preserving treatment of uterine leiomyoma]. Dnipro: Dnipro-VAL; 2017. 111 s. [Ukrainian]
3. Isniuk NO, Boichuk AV, Behosh BM, Onys'kiv BO. Kharakterystyka psykhoemotsiinoho statusu ta pokaznykiv yakosti zhyttia v zhinok iz fibromiomoiu matky ta poiednanoiu endokrynnoiu patolohiieiu [Characteristics of psychoemotional status and quality of life indicators in women with uterine fibroids and combined endocrine pathology]. Aktual'ni pytannia pediatrii, akusherstva ta hinekolohii. 2018;(1):76-9. [Ukrainian]
4. Salas A, López J, Reyes R, Évora C, de Oca FM, Báez D, et al. Organotypic culture as a research and preclinical model to study uterine leiomyomas. Sci Rep. 2020;10(1):5212-23. https://www.ncbi.nlm.nih.gov/pubmed/32251338. https://www.ncbi.nlm.nih.gov/pmc/articles/7090073. https://doi.org/10.1038/s41598-020-62158-w
5. Lin PH, Tung YT, Chen HY, Chiang YF, Hong HC, Huang KC, et al. Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation. J Pineal Res. 2020;68(1):12-20. https://doi.org/10.1111/jpi.12620
6. Boiko VI. Dyferentsiiovanyi pidkhid do khirurhichnoho likuvannia miomy matky velykykh rozmiriv [Differentiated approach to surgical treatment of large uterine fibroids]. Zdorovia zhinky. 2016;7(113):57-61. [Ukrainian]
7. Chill HH, Karavani G, Rachmani T, Dior U, Tadmor O, Shushan A. Growth pattern of uterine leiomyoma along pregnancy. BMC Womens Health. 2019;19(1):100-5. https://www.ncbi.nlm.nih.gov/pubmed/31331317. https://www.ncbi.nlm.nih.gov/pmc/articles/6647306. https://doi.org/10.1186/s12905-019-0803-5
8. Adamyan LV. Novye podkhody k medikamentoznomu lecheniyu simptomnoy miomy matki (obzor literatury) [New approaches to drug treatment of symptomatic uterine fibroids]. Problemy reproduktsii. 2013;(3):22-4. [Russian]
9. Khmil' SV, Drozdovs'ka YuB, Liubashevs'ka OR, Koblosh ND. Pohliady reproduktoloha na leiomiomu matky (ohliad literatury) [Views of the reproductive specialist on uterine leiomyoma]. Aktual'ni pytannia pediatrii, akusherstva ta hinekolohii. 2019;(2):78-82. [Ukrainian]. https://doi.org/10.11603/24116-4944.2019.2.10928
10. Yarots'kyi MIe, Hychka SH, Doroha OP, Yarots'ka IV, Dem’ianenko LV. Kliniko-morfolohichni osoblyvosti leiomiomy matky u zhinok reproduktyvnoho viku [Clinical and morphological features of uterine leiomyoma in women of reproductive age]. Endokrynolohiia. 2016;21(2):154-60. [Ukrainian]
11. Adamyan LV. Antiproliferativnoe i proapoptoticheskoe deystvie selektivnogo modulyatora retseptorov progesterona ulipristala na leyomiomu matki in vitro [Antiproliferative and proapoptotic effect of ulipristal, a selective progesterone receptor modulator, on uterine leiomyoma in vitro]. Problemy reproduktsii. 2014;(3):41-4. [Russian]
12. Baird DD, Kesner JS, Dunson DB. Luteinizing hormone in premenopausal women may stimulate uterine leiomyomata development. J Soc Gynecol Investig. 2006;13(2):130-5. https://www.ncbi.nlm.nih.gov/pubmed/16443507. https://doi.org/10.1016/j.jsgi.2005.12.001
13. Schoolmeester JK, Erickson LA. Uterine Leiomyoma. Mayo Clin Proc. 2019;94(10):2150-51. https://www.ncbi.nlm.nih.gov/pubmed/31585593. https://doi.org/10.1016/j.mayocp.2019.08.019
14. Wei JJ, Chiriboga L, Arslan AA, Melamed J, Yee H, Mittal K. Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Human Reproduction. 2006;21(1):57-67. https://www.ncbi.nlm.nih.gov/pubmed/16172143. https://doi.org/10.1093/humrep/dei309
15. Ciavattini A, Di Giuseppe J, Stortoni P, Montik N, Giannubilo SR, Litta P, et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int. 2013;2013:1-11. https://www.ncbi.nlm.nih.gov/pubmed/24163697. https://www.ncbi.nlm.nih.gov/pmc/articles/3791844. https://doi.org/10.1155/2013/173184
16. Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med. 2010;28(3):204-17. https://www.ncbi.nlm.nih.gov/pubmed/20414843. https://www.ncbi.nlm.nih.gov/pmc/articles/5330647. https://doi.org/10.1055/s-0030-1251477
17. Manta L, Suciu N, Toader O, Purcărea RM, Constantin A, Popa F. The etiopathogenesis of uterine fibromatosis. J Med Life. 2016;9(1):39-45.
18. Dronova VL, Dronov OI, Tesliuk RS. Psykholohichnyi stan patsiientok u do ta pisliaoperatsiinomu periodakh z hinekolohichnoiu ta khirurhichnoiu patolohiieiu, metody yoho vyznachennia (literaturnyi ohliad prats') [Psychological condition of patients in pre- and postoperative periods with gynecological and surgical pathology, methods of its determination]. Perynatolohiia ta pediatriia. 2017;1(69):65-9. [Ukrainian]. https://doi.org/10.15574/PP.2017.69.65
19. Sohn GS, Cho S, Kim YM, Cho CH, Kim MR, Lee SR; Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fibroids. Obstet Gynecol Sci. 2018;61(2):192-201. https://www.ncbi.nlm.nih.gov/pubmed/29564309. https://www.ncbi.nlm.nih.gov/pmc/articles/5854898. https://doi.org/10.5468/ogs.2018.61.2.192
20. Berbets' AM. Zminy snu, hormonal'noho balansu ta tsytokinovoho profiliu u vahitnykh z platsentarnoiu nedostatnistiu [Changes in sleep, hormonal balance and cytokine profile in pregnant women with placental insufficiency]. Zbirnyk naukovykh prats' asotsiatsii akusheriv-hinekolohiv Ukrainy. 2018;1(41):20-5. [Ukrainian]. https://doi.org/10.35278/2664-0767.1(41).2018.171293
21. Tan DX, Xu B, Zhou X, Reiter RJ. Pineal Calcification, Melatonin Production, Aging, Associated Health Consequences and Rejuvenation of the Pineal Gland. Molecules. 2018;23(2):301-32. https://www.ncbi.nlm.nih.gov/pubmed/29385085. https://www.ncbi.nlm.nih.gov/pmc/articles/6017004. https://doi.org/10.3390/molecules23020301.
22. Berbets' AM. Platsentarna nedostatnist', melatonin, pro- ta protyzapal'ni tsytokiny [Placental insufficiency, melatonin, pro- and anti-inflammatory cytokines]. Aktual'ni pytannia pediatrii, akusherstva ta hinekolohii. 2018;(1):76-9. [Ukrainian]
23. Bataeva AE, Ledenkova AA, Tikhomirov AA, Abyshova VG. Antagonisty retseptorov progesterona v strukture kompleksnogo organosokhranyayushchego lecheniya miomy matki [Antagonists of progesterone receptors in the structure of complex organ-preserving treatment of uterine fibroids]. Akusherstvo i ginekologiya. 2012;(5):115-9. [Russian]
24. Arnao MB, Hernández-Ruiz J. Melatonin and its relationship to plant hormones. Ann Bot. 2018;121(2):195-207. https://www.ncbi.nlm.nih.gov/pubmed/29069281. https://www.ncbi.nlm.nih.gov/pmc/articles/5808790. https://doi.org/10.1093/aob/mcx114.
25. Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018;46:3-11. https://www.ncbi.nlm.nih.gov/pubmed/29054502. https://doi.org/10.1016/j.bpobgyn.2017.09.004
26. Tamura H, Jozaki M, Tanabe M, Shirafuta Y, Mihara Y, Shinagawa M, et al. Importance of Melatonin in Assisted Reproductive Technology and Ovarian Aging. Int J Mol Sci. 2020;21(3):11-35. https://www.ncbi.nlm.nih.gov/pubmed/32046301. https://www.ncbi.nlm.nih.gov/pmc/articles/7036809. https://doi.org/10.3390/ijms21031135
27. Zare H, Shafabakhsh R, Reiter RJ, Asemi Z. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects. J Ovarian Res. 2019;12(1):26-34. https://www.ncbi.nlm.nih.gov/pubmed/30914056. https://www.ncbi.nlm.nih.gov/pmc/articles/6434863. https://doi.org/10.1186/s13048-019-0502-8
28. Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3-9. https://www.ncbi.nlm.nih.gov/pubmed/31960950. https://doi.org/10.1002/ijgo.13102
29. Naz S, Rehman A, Riyaz A, Jehangir F, Naeem S, Iqbal T. Leiomyoma: Its Variants And Secondary Changes A Five-Year Study. J Ayub Med Coll Abbottabad. 2019;31(2):192-5.
30. Grube M, Neis F, Brucker SY, Kommoss S, Andress J, Weiss M, et al. Uterine Fibroids - Current Trends and Strategies. Surg Technol Int. 2019;34:257-63.